Home Regulation of flavin-containing mono-oxygenase (Fmo3) gene expression by steroids in mice and humans
Article
Licensed
Unlicensed Requires Authentication

Regulation of flavin-containing mono-oxygenase (Fmo3) gene expression by steroids in mice and humans

  • Teresa Esposito , Bruno Varriale EMAIL logo , Rosalia D’Angelo , Aldo Amato and Antonina Sidoti
Published/Copyright: December 2, 2014

Abstract

Flavin-containing mono-oxygenases (FMOs) are a family of microsomal chemical- and drug-metabolizing enzymes. FMO3 is a major FMO form in adult mouse and human liver. FMO3 mutations have been associated with the incidence and severity of trimethylaminuria (TMAU), a metabolic disorder characterized by the inability of the affected individual to metabolize the odorous trimethylamine to its non-odorous N-oxide. In addition to this primary genetic form, there are other forms of TMAU that support the hypothesis that FMO3 activity may be modulated by steroid hormones. To understand the molecular mechanism involved in the regulation of Fmo3 gene expression by steroid hormones, we performed this study in an in vitro cellular system, mouse liver cells, and on the human FMO3 gene. Dexamethasone, 5α-dihydrotestosterone, thyroid hormone, and progesterone had no effect on the accumulation of Fmo3 mRNA. The use of increased concentration of theophylline inhibited estrogen receptor α (ERα)-mediated transcription of Fmo3 mRNA. 17β-Estradiol inhibited Fmo3 mRNA accumulation. The use of ICI 164,384 abolished the inhibitory effect induced by estrogen. Gel-shift analyses showed a binding in the 5′ region of the Fmo3 gene. This binding was abrogated by an excess of a cDNA containing an estrogen-responsive element. An estrogen-binding site was also present in the first intron of the human gene, as demonstrated by the gel-shift assay. Supershift experiments confirmed the binding of ERα in both mouse and human samples. Furthermore, chromatin immunoprecipitation assay confirmed the binding of ERα in the promoter region of mouse Fmo3 and in the first intron of the human FMO3 gene. Thus, 17β-estradiol plays a fundamental role in the regulation of Fmo3 gene transcription.


Corresponding author: Prof. Bruno Varriale, Department of Experimental Medicine, Sec. “Bottazzi”, Second University of Naples, Via Costantinopoli 16, 80138 Naples, Italy, Phone: +3981-5667621, Fax: +3981-5667500, E-mail:
aThese authors contributed equally to this work.

References

1. Ziegler DM. Recent studies on the structure and function of multi-substrate flavin-containing monooxygenases. Ann Rev Pharmacol Toxicol 1993;33:179–89.10.1146/annurev.pa.33.040193.001143Search in Google Scholar

2. Hines RN, Cashman JR, Philpot RM, Williams DE, Ziegler DM. The mammalian flavin-containing monooxygenase: molecular characterization and regulation expression. Toxicol Appl Pharmacol 1994;125:1–6.10.1006/taap.1994.1042Search in Google Scholar

3. Krueger SK, Williams DE. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 2005;106:357–87.10.1016/j.pharmthera.2005.01.001Search in Google Scholar

4. Cashman JR, Zhang J. Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 2006;46:65–100.10.1146/annurev.pharmtox.46.120604.141043Search in Google Scholar

5. Hines RN, Hopp KA, Franco J, Saeian K, Begun FP. Alternative processing of the human FMO6 gene renders transcripts incapable of encoding a functional flavin-containing monooxygenase. Mol Pharmacol 2002;62:320–5.10.1124/mol.62.2.320Search in Google Scholar

6. Motika MS, Zhang J, Cashman JR. Flavin-containing monooxygenase 3 and human disease. Expert Opin Drug Metab Toxicol 2007;3:831–45.10.1517/17425255.3.6.831Search in Google Scholar

7. Atta-Asafo-Adjei E, Lawton MP, Philpot RM. Cloning, sequencing, distribution, and expression in Escherichia coli of flavin-containing monooxygenase 1C1. Evidence for a third gene subfamily in rabbits. J Biol Chem 1993;268:9681–9.10.1016/S0021-9258(18)98403-6Search in Google Scholar

8. Lawton MP, Philpot RM. Functional characterization of flavin-containing monooxygenase 1B1 expressed in Saccharomyces cerevisiae and Escherichia coli and analysis of proposed FAD and membrane-binding domains. J Biol Chem 1993;268: 5728–34.10.1016/S0021-9258(18)53379-2Search in Google Scholar

9. Lawton MP, Cashman JR, Cresteil T, Dolphin C, Elfarra A, Hines RN, Hodgson E, Kimura T, Ozols J, Phillips I. A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities. Arch Biochem Biophys 1994;308:254–7.10.1006/abbi.1994.1035Search in Google Scholar PubMed

10. Cashman JR. Structural and catalytic properties of the mammalian flavin-containing monooxygenases. Chem Res Toxicol 1995;8:165–8.10.1021/tx00044a001Search in Google Scholar PubMed

11. Phillips IR, Dolphin CT, Clair P, Hadley MR, Hutt AJ, McCombie RR. The molecular biology of the flavin-containing monooxygenases of man. Chem Biol Interact 1995;96:17–32.10.1016/0009-2797(94)03580-2Search in Google Scholar

12. Krueger SK, Williams DE, Yueh MF, Martin SR, Hines RN, Raucy JL, Dolphin CT, Shephard EA, Phillips IR. Genetic polymorphisms of flavin-containing monooxygenase (FMO). Drug Metab Rev 2002;34:523–32.10.1081/DMR-120005653Search in Google Scholar

13. Hernandez D, Janmohamed A, Chandan P, Phillips IR, Shephard EA. Organization and evolution of the flavin-containing monooxygenase (FMO) genes human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics 2004;14:117–30.10.1097/00008571-200402000-00006Search in Google Scholar

14. Falls JG, Blake BL, Cao Y, Levi PE, Hodgson E. Gender differences in hepatic expression of flavin-containing monooxygenase isoforms (FMO1, FMO3, and FMO5) in mice. J Biochem Toxicol 1995;10:171–7.10.1002/jbt.2570100308Search in Google Scholar

15. Park SB, Jacob P 3rd, Benowitz NL, Cashman JR. Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1′-oxide. Chem Res Toxicol 1993;6:880–8.10.1021/tx00036a019Search in Google Scholar

16. Cashman JR, Yang Z, Yang L, Wrighton SA. Stereo- and regioselective N- and S-oxidation of tertiary amines and sulfides in the presence of adult human liver microsomes. Drug Metab Dispos 1993;21:492–501. Erratum in: Drug Metab Dispos Biol Fate Chem 1993;21:174.Search in Google Scholar

17. Sadeque AJ, Eddy AC, Meier GP, Rettie AE. Stereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms. Drug Metab Dispos 1992;20:832–9.Search in Google Scholar

18. Sadeque AJ, Thummel KE, Rettie AE. Purification of macaque liver flavin-containing monooxygenase: a form of the enzyme related immunochemically to an isozyme expressed selectively in adult human liver. Biochim Biophys Acta 1993;1162:127–34.10.1016/0167-4838(93)90138-HSearch in Google Scholar

19. Dolphin C, Shephard EA, Povey S, Palmer CN, Ziegler DM, Ayesh R, Smith RL, Phillips IR. Cloning, primary sequence, and chromosomal mapping of a human flavin-containing monooxygenase (FMO1). J Biol Chem 1991;266:12379–85.10.1016/S0021-9258(18)98908-8Search in Google Scholar

20. Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, Hines RN. Human hepatic flavin-containing monooxygenase 1 (FMO3) and 3 (FMO3) developmental expression. Pediatr Res 2002;51:236–43.10.1203/00006450-200202000-00018Search in Google Scholar PubMed

21. Cashman JR, Bi YA, Lin J, Youil R, Knight M, Forrest S, Treacy E. Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria. Chem Res Toxicol 1997;10:837–41.10.1021/tx9700533Search in Google Scholar PubMed

22. Cashman JR. Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism. Curr Drug Metab 2000;1:181–92.10.2174/1389200003339135Search in Google Scholar PubMed

23. Cashman JR. Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism. Pharmacogenomics 2002;3:325–39.10.1517/14622416.3.3.325Search in Google Scholar PubMed

24. Cashman JR, Camp K, Fakharzadeh SS, Fennessey PV, Hines RN, Mamer OA, Mitchell SC, Nguyen GP, Schlenk D, Smith RL, Tjoa SS, Williams DE, Yannicelli S. Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. Curr Drug Metab 2003;4:151–70.10.2174/1389200033489505Search in Google Scholar PubMed

25. Zhang J, Tran Q, Lattard V, Cashman JR. Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria. Pharmacogenetics 2003;13:495–500.10.1097/00008571-200308000-00007Search in Google Scholar PubMed

26. Cashman JR, Zhang J, Leushner J, Braun A. Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms. Drug Metab Dispos 2001;29:1629–37.Search in Google Scholar

27. Dolphin CT, Janmohamed A, Smith RL, Shephard EA, Phillips IR. Missense mutation in flavin-containing monooxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nat Genet 1997;17:491–4.10.1038/ng1297-491Search in Google Scholar PubMed

28. Kang JH, Chung WG, Lee KH, Park CS, Kang JS, Shin IC, Roh HK, Dong MS, Baek HM, Cha YN. Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N oxidation are positively correlated with genotypes of linked FM03 gene mutations in a Korean population. Pharmacogenetics 2000;10:67–78.10.1097/00008571-200002000-00009Search in Google Scholar PubMed

29. Murphy HC, Dolphin CT, Janmohamed A, Holmes HC, Michelakakis H, Shephard EA, Chalmers RA, Phillips IR, Iles RA. A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy. Pharmacogenetics 2000;10:439–51.10.1097/00008571-200007000-00007Search in Google Scholar PubMed

30. Forrest SM, Knight M, Akerman BR, Cashman JR, Treacy EP. A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria. Pharmacogenetics 2001;11:169–74.10.1097/00008571-200103000-00007Search in Google Scholar PubMed

31. Cashman JR, Zhang J. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation. Drug Metab Dispos 2002;30:1043–52.10.1124/dmd.30.10.1043Search in Google Scholar PubMed

32. Park CS, Kang JH, Chung WG, Yi HG, Pie JE, Park DK, Hines RN, McCarver DG, Cha YN. Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities. Pharmacogenetics 2002;12:77–80.10.1097/00008571-200201000-00011Search in Google Scholar PubMed

33. Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR. Trimethylaminuria and a human FMO3 mutation database. Hum Mutat 2003;22:209–13.10.1002/humu.10252Search in Google Scholar PubMed

34. Lattard V, Longin-Sauvageon C, Benoit E. Cloning, sequencing and tissue distribution of rat flavin-containing monooxygenase 4: two different forms are produced by tissue-specific alternative splicing. Mol Pharmacol 2003;63:253–61.10.1124/mol.63.1.253Search in Google Scholar

35. Lattard V, Zhang J, Tran Q, Furnes B, Schlenk D, Cashman JR. Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies. Drug Metab Dispos 2003;31:854–60. Erratum in: Drug Metab Dispos 2003;32:280.Search in Google Scholar

36. Zhang AQ, Mitchell SC, Smith RL. Exacerbation of symptoms of fish-odour syndrome during menstruation. Lancet 1996;348:1740–1.10.1016/S0140-6736(05)65872-2Search in Google Scholar

37. Yamazaki H, Fujieda M, Togashi M, Saito T, Preti G, Cashman JR, Kamataki T. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients. Life Sci 2004;74:2739–47.10.1016/j.lfs.2003.10.022Search in Google Scholar

38. Shimizu M, Cashman JR, Yamazaki H. Transient trimethylaminuria related to menstruation. BMC Med Genet 2007;8:2.10.1186/1471-2350-8-2Search in Google Scholar

39. Danks DM, Hammond J, Schlesinger P, Faull K, Burke D, Halpern B. Trimethylaminuria: diet does not always control the fishy odor. N Engl J Med 1976;295:962.10.1056/NEJM197610212951718Search in Google Scholar

40. Marks R, Greaves MW, Danks D, Plummer V. Proceedings: trimethylaminuria or fish odour syndrome in a child. Br J Dermatol 1976;95(Suppl 14):11–2.10.1111/j.1365-2133.1976.tb07880.xSearch in Google Scholar

41. Zhou J, Shephard EA. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3. Mutat Res 2006;612:165–71.10.1016/j.mrrev.2005.09.001Search in Google Scholar

42. Mitchell SC, Zhang A, Smith RL. Fish-odour syndrome and impaired N-oxidation. Biochem Soc Trans 1996;24:96S.10.1042/bst024096sSearch in Google Scholar

43. Mitchell SC, Smith RL. Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos 2001;29:517–21.Search in Google Scholar

44. Falls JG, Ryu DY, Cao Y, Levi PE, Hodgson E. Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. Arch Biochem Biophys 1997;342:212–23.10.1006/abbi.1997.9965Search in Google Scholar

45. Schlenk D, El-Alfy A, Buhler DR. Down regulation of hepatic flavin-containing monooxygenase activity by 17β-estradiol in rainbow trout (Oncorhynchus mykiss). Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1997;118:199–202.10.1016/S0742-8413(97)00139-4Search in Google Scholar

46. Duffel MW, Graham JM, Ziegler DM. Changes in dimethylaniline N-oxidase activity of mouse liver and kidney induced by steroid sex hormones. Mol Pharmacol 1981;19:134–9.Search in Google Scholar

47. Dannan GA, Guengerich FP, Waxman DJ. Hormonal regulation of rat liver microsomal enzymes. Role of gonadal steroids in programming, maintenance, and suppression of δ4-steroid 5α-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450. J Biol Chem 1986;261:10728–35.10.1016/S0021-9258(18)67446-0Search in Google Scholar

48. Klick DE, Shadley J D, Hines RN. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein β (C/EBPβ) liver inhibitory and liver activating proteins. Biochem Pharm 2008;76:268–78.10.1016/j.bcp.2008.05.002Search in Google Scholar

49. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 1987;162:156–9.10.1016/0003-2697(87)90021-2Search in Google Scholar

50. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Addendum. Anal Biochem 1984;137:266–7.Search in Google Scholar

51. Sambrook Y, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor, 1989.Search in Google Scholar

52. Varriale B, Tata JR. Autoinduction of estrogen receptor is associated with FOSP-1 mRNA induction by estrogen in primary cultures of Xenopus oviduct cells. Mol. Cell Endocrinol 1990;71:R25–31.10.1016/0303-7207(90)90035-7Search in Google Scholar

53. Mao C, Patterson NM, Cherian MT, Aninye IO, Zhang C, Montoya JB, Cheng J, Putt KS, Hergenrother PJ, Wilson EM, Nardulli AM, Nordeen SK, Shapiro DJ. A new small molecule inhibitor of estrogen receptor α binding to estrogen responsive elements blocks estrogen-dependent growth of cancer cells. J Biol Chem 2008;283:12819–30.10.1074/jbc.M709936200Search in Google Scholar

54. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding protein from limiting number of mammalian cells. Nucleic Acids Res 1991;19:2499.10.1093/nar/19.9.2499Search in Google Scholar

55. Shadley JD, Divakaran K, Munson K, Hines RN, Douglas K, McCarver DG. Identification and functional analysis of a novel human CYP2E1 far up stream enhancer. Mol Pharmacol 2007;71:1630–9.10.1124/mol.106.031302Search in Google Scholar

56. Robyr D, Gegonne A, Wolffe AP, Wahli W. Determinants of vitellogenin B1 promoter architecture HNF3 and estrogen responsive transcription within chromatin. J Biol Chem 2000;275:28291–300.10.1074/jbc.M002726200Search in Google Scholar

57. Coecke S, Debast G, Phillips IR, Vercruysse A, Shephard EA, Rogiers V. Hormonal regulation of microsomal flavin-containing monooxygenase activity by sex steroids and growth hormone in co-cultured adult male rat hepatocytes. Biochem Pharmacol 1998;56:1047–51.10.1016/S0006-2952(98)00104-XSearch in Google Scholar

Received: 2014-7-7
Accepted: 2014-10-24
Published Online: 2014-12-2
Published in Print: 2014-12-1

©2014 by De Gruyter

Downloaded on 28.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2014-0012/pdf
Scroll to top button